Literature DB >> 18456716

Contribution of PTEN large rearrangements in Cowden disease: a multiplex amplifiable probe hybridisation (MAPH) screening approach.

F Chibon1, C Primois, J-M Bressieux, D Lacombe, C Lok, L Mauriac, A Taieb, M Longy.   

Abstract

BACKGROUND: Cowden disease is an autosomal dominant syndrome predisposing to cancer and characterised by the occurrence throughout life of hyperplastic, hamartomatous and tumoural lesions affecting various organs. In 60-80% of patients a germline intragenic point mutation of the PTEN tumour suppressor gene is identified, but at least 20% of patients with a well characterised phenotype remain without any identified mutation.
METHODS: To evaluate the impact of large rearrangement involving the PTEN locus in Cowden disease, we analysed by a multiplex amplifiable probe hybridisation (MAPH) technique 80 unrelated patients referred for diagnosed or suspected Cowden disease, and in whom no PTEN point mutation was detected by a denaturing gradient gel electrophoresis (DGGE) screening.
RESULTS: Four heterozygous genomic deletions involving the PTEN gene were identified. These deletions ranged from 13.6-662 kb and are restricted to the PTEN locus in two cases. In the two other cases, the deletion encompassed PTEN and either two or three contiguous genes without any obvious phenotypic effect, except a possible consequence of PAPSS2 haploinsufficiency on bone growth. Sequence analysis of the four deleted alleles did not reveal identity or sequence homology at the two breakpoints of a same allele, suggesting that a mechanism such as non-homologous recombination of the breakage and reunion type could lead to the occurrence of these deletions.
CONCLUSION: Large rearrangements of the PTEN gene can be involved as causing mutation in Cowden disease and MAPH is an efficient screening methodology to detect such a genetic alteration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456716     DOI: 10.1136/jmg.2008.058131

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome.

Authors:  Erin E Salo-Mullen; Jinru Shia; Isaac Brownell; Peter Allen; Monica Girotra; Mark E Robson; Kenneth Offit; Jose G Guillem; Arnold J Markowitz; Zsofia K Stadler
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

2.  Frequency of germline PTEN mutations in differentiated thyroid cancer.

Authors:  Rebecca Nagy; Shireen Ganapathi; Ilene Comeras; Charissa Peterson; Mohammed Orloff; Kyle Porter; Charis Eng; Matthew D Ringel; Richard T Kloos
Journal:  Thyroid       Date:  2011-03-21       Impact factor: 6.568

3.  A new case with 10q23 interstitial deletion encompassing both PTEN and BMPR1A narrows the genetic region deleted in juvenile polyposis syndrome.

Authors:  Marija Hiljadnikova Bajro; Elena Sukarova-Angelovska; Jose Adélaïde; Max Chaffanet; Aleksandar J Dimovski
Journal:  J Appl Genet       Date:  2012-09-21       Impact factor: 3.240

Review 4.  Cowden syndrome: a critical review of the clinical literature.

Authors:  Robert Pilarski
Journal:  J Genet Couns       Date:  2008-10-30       Impact factor: 2.537

Review 5.  Genetic testing for hereditary colorectal cancer.

Authors:  Heather Hampel
Journal:  Surg Oncol Clin N Am       Date:  2009-10       Impact factor: 3.495

6.  Correlations between long inverted repeat (LIR) features, deletion size and distance from breakpoint in human gross gene deletions.

Authors:  Nevim Aygun
Journal:  Sci Rep       Date:  2015-02-06       Impact factor: 4.379

7.  Gene Dosage Analysis in a Clinical Environment: Gene-Targeted Microarrays as the Platform-of-Choice.

Authors:  Renate Marquis-Nicholson; Debra Prosser; Jennifer M Love; Donald R Love
Journal:  Microarrays (Basel)       Date:  2013-03-27

8.  First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.

Authors:  Markus W Löffler; Julia Steinhilber; Franz J Hilke; Sebastian P Haen; Hans Bösmüller; Ivonne-Aidee Montes-Mojarro; Irina Bonzheim; Antje Stäbler; Ulrike Faust; Ute Grasshoff; Ingmar Königsrainer; Hans-Georg Rammensee; Lothar Kanz; Alfred Königsrainer; Stefan Beckert; Olaf Riess; Christopher Schroeder
Journal:  BMC Med Genet       Date:  2018-08-15       Impact factor: 2.103

9.  Clustering of sebaceous gland carcinoma, papillary thyroid carcinoma and breast cancer in a woman as a new cancer susceptibility disorder: a case report.

Authors:  Brian D Newman; Joseph F Maher; Jose S Subauste; Gabriel I Uwaifo; Steven A Bigler; Christian A Koch
Journal:  J Med Case Rep       Date:  2009-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.